Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study

Liver Transplantation

Volumn 17, Issue 7, 2011, Pages 855-865

  Bresson Hadni, Solange ^a   Blagosklonov, Oleg ^a   Knapp, Jenny ^a,b   Grenouillet, Frédéric ^a   Sako, Yasuhito ^b   Delabrousse, Eric ^a   Brientini, Marie Pascale ^a   Richou, Carine ^a   Minello, Anne ^a,c   Antonino, Anca Teodora ^d,e   Gillet, Michel ^d,e   Ito, Akira ^b   Mantion, Georges André ^a   Vuitton, Dominique Angéle ^a,f  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d Departments of Gastroenterology and Hepatology   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; AZATHIOPRINE; BENZIMIDAZOLE DERIVATIVE; CYCLOSPORIN; EM18 ANTIGEN; EM2 PLUS ANTIGEN; FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT; MEBENDAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT ANTIGEN; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LETHALITY; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PATIENT COMPLIANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT;

ADULT; BENZIMIDAZOLES; ECHINOCOCCOSIS, HEPATIC; END STAGE LIVER DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79959818108     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22299     Document Type: Article

References (33)

1. Bresson-Hadni S, Miguet JP, Mantion GA, Vuitton DA,. Echinococcosis of the liver. In:, Rodes J, Benhamou JP, Blei AT, Reichen J, Rizzetto M, eds. Textbook of Hepatology: From Basic Science to Clinical Practice. Vol 1. 3rd ed. Oxford, United Kingdom: Blackwell Publishing; 2007: 1047-1057.
2. Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, et al. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 2008; 49: 72-77.
3. World Health Organization Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull World Health Organ 1996; 74: 231-242.
4. Bresson-Hadni S, Franza A, Miguet JP, Vuitton DA, Lenys D, Monnet E, et al. Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases. Hepatology 1991; 13: 1061-1070.
5. Liance M, Bresson-Hadni S, Vuitton DA, Lenys D, Carbillet JP, Houin R,. Effects of cyclosporin A on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularis. Int J Parasitol 1992; 22: 23-28.
6. Bresson-Hadni S, Koch S, Beurton I, Vuitton DA, Bartholomot B, Hrusovsky S, et al. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients. Hepatology 1999; 30: 857-864. (Pubitemid 29458271)
7. Koch S, Bresson-Hadni S, Miguet JP, Crumbach JP, Gillet M, Mantion GA, et al. Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report. Transplantation 2003; 75: 856-863. (Pubitemid 36373460)
8. Reuter S, Schirrmeister H, Kratzer W, Dreweck C, Reske SN, Kern P,. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clin Infect Dis 1999; 29: 1157-1163. (Pubitemid 30265633)
9. Stumpe KD, Renner-Schneiter EC, Kuenzle AK, Grimm F, Kadry Z, Clavien PA, et al. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 2007; 35: 11-18. (Pubitemid 46295046)
10. Gottstein B, Jacquier P, Bresson-Hadni S, Eckert J,. Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen. J Clin Microbiol 1993; 31: 373-376. (Pubitemid 23028643)
11. Sako Y, Nakao M, Nakaya K, Yamasaki H, Gottstein B, Lightowers MW, et al. Alveolar echinococcosis: characterization of diagnostic antigen Em18 and serological evaluation of recombinant Em18. J Clin Microbiol 2002; 40: 2760-2765. (Pubitemid 35284938)
12. Bart JM, Piarroux M, Sako Y, Grenouillet F, Bresson-Hadni S, Piarroux R, Ito A,. Comparison of several commercial serologic kits and Em18 serology for detection of human alveolar echinococcosis. Diagn Microbiol Infect Dis 2007; 59: 93-95. (Pubitemid 47391169)
13. Tappe D, Frosch M, Sako Y, Itoh S, Grüner B, Reuter S, et al. Close relationship between clinical regression and specific serology in the follow-up of patients with alveolar echinococcosis in different clinical stages. Am J Trop Med Hyg 2009; 80: 792-797.
14. Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, et al. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 2004; 39: 509-517. (Pubitemid 38222193)
15. Kern P, Wen H, Sato N, Vuitton DA, Gruener B, Shao Y, et al. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 2006; 55 (suppl): S283-S287. (Pubitemid 43191989)
16. Gottstein B,. Purification and characterization of a specific antigen from Echinococcus multilocularis. Parasite Immunol 1985; 7: 201-212. (Pubitemid 15039645)
17. Marriner SE, Morris DL, Dickson B, Bogan JA,. Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 1986; 30: 705-708. (Pubitemid 16018950)
18. Li T, Ito A, Chen X, Sako Y, Qiu J, Xiao N, et al. Specific IgG responses to recombinant antigen B and Em18 in cystic and alveolar echinococcosis in China. Clin Vaccine Immunol 2010; 17: 470-475.
19. Chapuis Y, Houssin D, Brouzes S, Ortega D,. Hepatic transplantation in alveolar echinococcosis. 3 attempts [in French]. Chirurgie 1987; 113: 634-640. (Pubitemid 18073340)
20. Bresson-Hadni S, Vuitton DA, Bartholomot B, Heyd B, Godart D, Meyer JP, et al. A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol 2000; 12: 327-336. (Pubitemid 30168588)
21. Bresson-Hadni S, Miguet JP, Lenys D, Vuitton DA, Viennet G, Becker MC, et al. Recurrence of alveolar echinococcosis in the liver graft after liver transplantation. Hepatology 1992; 16: 279-280.
22. Brunetti E, Kern P, Vuitton DA,. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010; 114: 1-16.
23. Xia D, Yan LN, Li B, Zeng Y, Cheng NS, Wen TF, et al. Orthotopic liver transplantation for incurable alveolar echinococcosis: report of five cases from west China. Transplant Proc 2005; 37: 2181-2184. (Pubitemid 40956406)
24. Moray G, Shahbazov R, Sevmis S, Karakayali H, Torgay A, Arslan G, et al. Liver transplantation in management of alveolar echinococcosis: two case reports. Transplant Proc 2009; 41: 2936-2938.
25. Haider HH, Nishida S, Selvaggi G, Levi D, Tekin A, Moon JI, Tzakis AG,. Alveolar echinococcosis induced liver failure: salvage by liver transplantation in an otherwise uniformly fatal disease. Clin Transplant 2008; 22: 664-667.
26. Vuitton DA, Zhang SL, Yang Y, Godot V, Beurton I, Mantion G, Bresson-Hadni S,. Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int 2006; 55 (suppl): S51-S55. (Pubitemid 43188928)
27. Godot V, Harraga S, Podoprigora G, Liance M, Bardonnet K, Vuitton DA,. IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses. Gastroenterology 2003; 124: 1441-1450. (Pubitemid 36531817)
28. Vuitton DA, Gottstein B,. Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay. J Biomed Biotechnol 2010; 2010: 923193.
29. Li T, Zhao JM, Paizula A, Shao YM, Wen H,. Study on immune tolerance on orthotopic liver transplantation in the inbred rat infected with Echinococcus multilocularis. J Xinjiang Med Univ 2006; 29: 940-942.
30. Gottstein B,. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev 1992; 5: 248-261.
31. Fujimoto Y, Ito A, Ishikawa Y, Inoue M, Suzuki Y, Ohhira M, et al. Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis. J Gastroenterol 2005; 40: 426-431.
32. Ishikawa Y, Sako Y, Itoh S, Ohtake T, Kohgo Y, Matsuno T, et al. Serological monitoring of progression of alveolar echinococcosis with multiorgan involvement by use of recombinant Em18. J Clin Microbiol 2009; 47: 3191-3196.
33. Crouzet J, Grenouillet F, Delabrousse E, Blagosklonov O, Thevenot T, Di Martino V, et al. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up. Clin Microbiol Infect 2010; 16: 788-791.